Conventional prostate cancer staging strategies have limited accuracy to define the location,
grade, and burden of disease. Evaluations have historically relied upon prostate-specific …

Prostate cancer (PCa) is the most common noncutaneous malignancy in men and the
second leading cause of cancer related death in the United States. Men with clinical …

Accurate staging is critical for treatment planning and prognosis in men with prostate
Cancer. Prostate magnetic imaging resonance (MRI) may aid in the staging evaluation by …

Approximately 15% of men with newly diagnosed prostate cancer have high-risk disease.
Imaging is critically important for the diagnosis and staging of these patients, and also for the …

Imaging is critically important for the diagnosis, staging, and management of men with high-
risk prostate cancer. Conventional imaging modalities have been employed for local and …

To assess and validate the incorporation of the multiparametric magnetic resonance
imaging (mpMRI) tumour category (mT-category) to the conventional clinical tumour …

Prostate cancer is the most commonly diagnosed malignancy and the second most common
cause of cancer death of men in the United States [1]. Appropriate imaging is a crucial …

Recent developments in (molecular) imaging technologies have led to significant changes
in diagnostic, staging, and therapeutic processes in prostate cancer (PCa). The recent …

Imaging is becoming critical for guiding management decisions in prostate cancer (PCa)
both at initial diagnosis and at recurrence. Multiparametric magnetic resonance imaging …

Purpose To explore the prostate-specific membrane antigen (PSMA)–avid distribution of
prostate cancer (PC) on positron emission tomography (PET), both at the time of initial …